InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: None

Monday, 08/13/2018 8:27:39 AM

Monday, August 13, 2018 8:27:39 AM

Post# of 438
Aratana Therapeutics (PETX)

Engaged Capital bought 842,312 shares of the pet therapeutics company from July 31 through August 7 at prices ranging from $4.22 to $4.98 per share, increasing its stake to 3,242,312 shares or 6.8% of the outstanding stock.

Engaged had entered into a cooperation agreement with the issuer in May, with the company agreeing to appoint two designees of Engaged to its board and establish an ad hoc strategic review committee.


from Dow Jones as reported by broker 8/10/18

I am less than enthusiastic about the fact. There was futile resistance by PETX.

My own worthless opinion is that while the news may attract more new buyers the relationship is not likely salubrious longer term.

Best, Terry
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.